Taken together, the previous studies and our results indicate similar cardioprotection of PFD and losartan, which may be attributed to the effects on RAS axes by alteration of the ACE/ACE2 ratio. The gene discussed is ACE2; the disease is polyostotic fibrous dysplasia.